Cited by 179Menopause: Health Impacts and TreatmentsHormonal and reproductive studiesDiabetes, Cardiovascular Risks, and Lipoproteins

The Association of Endogenous Sex Hormones, Adiposity, and Insulin Resistance with Incident Diabetes in Postmenopausal Women

Open access
Kalyani, Rita Rastogi, Franco, Manuel, Dobs, Adrian S., Ouyang, Pamela, Vaidya, Dhananjay, Bertoni, Alain, Gapstur, Susan M., Golden, Sherita Hill·2009·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: In postmenopausal women, endogenous bioavailable testosterone (T) and estradiol (E2) have been positively associated, and SHBG has been negatively associated, with incident type 2 diabetes (T2DM). Previous studies have not explored possible factors explaining these relationships. OBJECTIVE: Our objective was to examine the association of endogenous sex hormones with incident T2DM in postmenopausal women and possible explanatory factors. DESIGN, SETTING, AND PARTICIPANTS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective study that included 1612 postmenopausal women aged 45-84 yr, followed between the years 2000-2006, who were not taking hormone replacement therapy, had no prevalent cardiovascular disease or diabetes, and had complete ascertainment of sex hormones. MAIN OUTCOME MEASURES: T2DM was defined based on fasting glucose and/or treatment for diabetes. RESULTS: There were 116 incident cases of diabetes during follow-up. Across higher quartiles of bioavailable T and E2 and lower quartiles of SHBG, we found significantly greater hazards of developing incident T2DM (all P for trend <or=0.001). After adjustment for body mass index and insulin resistance estimated by homeostasis model assessment of insulin resistance, bioavailable T was no longer associated with incident T2DM. The associations of E2 and SHBG with incident T2DM were partially explained by body mass index and insulin resistance but persisted in fully adjusted models (both P for trend <0.02). Dehydroepiandrosterone had no relationship with incident T2DM. CONCLUSIONS: Adiposity and insulin resistance explained most of the association of bioavailable T but only partially explained the associations of E2 and SHBG with incident T2DM among postmenopausal women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2009-0910

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The same inverse association between SHBG and T2D has been confirmed in multiple other studies in both men and women.

    “The same inverse association between SHBG and T2D has been confirmed in multiple other studies in both men and women [120–123].”

    From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [121]

    The Multivariable analyses section (page not available) reports an inverse association between SHBG and incident T2D in postmenopausal women. The SHBG section says this corroborates a previous finding, but the paper does not establish the claim that multiple other studies confirmed the association in both men and women. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The association between SHBG and T2D holds after adjusting for BMI and other common risk factors, implying lower SHBG as a predictor for T2D is at least partially independent of BMI.

    “Importantly, the association between SHBG and T2D also holds after adjusting for BMI and other common risk factors, implying lower SHBG as a predictor for T2D is at least partially independent of BMI [118, 121, 124].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Ding EL, Song Y, Malik VS, Liu S 2006 Sex differences of endog- enous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288 -1299

Cited by

Sorted by citations

Authors
Kalyani, R. R., Franco, M., Dobs, A. S., Ouyang, P., Vaidya, D., Bertoni, A., Gapstur, S. M., & Golden, S. H.
Affiliations
  • Johns Hopkins University (US)
  • Spanish National Centre for Cardiovascular Research (ES)
  • Wake Forest University (US)
  • American Cancer Society (US)
Corresponding author
Golden, Sherita Hill
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-11-01
Volume
94
Issue
11
Pages
4127-4135
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2165285485
Cited by
179
References
7
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 10 · 2021: 10 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 19 · 2016: 20 · 2015: 19 · 2014: 8 · 2013: 11 · 2012: 19
FWCI
8.74
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health (n01hc095169-003, N01-HC- 95159, 5k23dk071565-05, n01hc95159-40-0-1, N01‐HC‐95169)
  • National Heart, Lung, and Blood Institute (N01 HC-95159, N01-HC095169, N01-HC-095159, N01 HC95169)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK071565, 5 K23 DK071565, P30DK079637)
  • National Center for Research Resources (N01 HC 95169, N01-HC-95159, KL2RR025006)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, postmenopausal women, endogenous sex hormones, bioavailable testosterone, estradiol, sex hormone-binding globulin, dehydroepiandrosterone, adiposity, body mass index, insulin resistance, HOMA-IR, incident diabetes risk
MeSH terms
Adipose Tissue, Aged, Aged, 80 and over, Blood Glucose, Dehydroepiandrosterone, Diabetes Mellitus, Diabetes Mellitus, Type 2, Estradiol, Ethnicity, Fasting, Female, Humans, Longitudinal Studies, Middle Aged, Sex Hormone-Binding Globulin, Testosterone, Cohort Studies, Proportional Hazards Models, Postmenopause, Glucose Intolerance, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review